The mechanisms of postponing the application of anti-PD-1 antibody for 2 days when combined with chemotherapy with anti-PD-1 antibody may be as follows: studies in preclinical animal models found that cyclophosphamide could upregulate PD-1 and PD-L1 expression on tumor-specific CD8+ T cells in tumor-bearing C3 mice. The gene discussed is CD274; the disease is neoplasm.